6505--Notice of Intent to Sole Source Procurement - Flyrcado (F18 Flurpiridaz) Injection
Veterans Affairs · 257-NETWORK CONTRACT OFFICE 17 (36C257)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25726Q0205 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
Presolicitation Notice Notice of Intent to Award a Sole Source Procurement The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced contract to Medi-Physics, Inc. for the procurement of the following item: 0001: Flyrcado (flurpiridaz F-18) Injection, Unit of Issue: EA (mCi), Qty.: 990 The proposed sole source procurement will be made with a price that has been established on GE Healthcare s VA NAC contract 36F79725D0214. GE Healthcare has stated that orders for Flyrcado must be placed as open market orders to Medi-P… (show all)
hysics, Inc. This notice is not to be considered a request for quotations or proposals. No contract will be awarded based on offers received in response to this notice; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 7 days from the publication of this notice, a contract or order will be issued to Cardinal Health without any further notice. The anticipated statutory authority permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, only one responsible source and no other supplies or services will satisfy agency requirements.
Who won similar work
8 award notices on SAM.gov in the last 24 months. Matched by: Same office (257-NETWORK CONTRACT OFFICE 17 (36C257)), same product/service code (PSC) 6505 and NAICS 325412.
Single-winner award sizes (8): middle half $209K to $1.2M, median $775K; range $41K to $1.9M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| PANHANDLE NUCLEAR RX, LTD. | 2 | $762K | May 1, 2026 |
| CARDINAL HEALTH 414, LLC · $CAH · $254.2B | 1 | $1.9M | Jan 29, 2025 |
| SOFIE Co. Dulles VA 20166 USA | 1 | $1.2M | Nov 26, 2024 |
| OPTUM INFUSION SERVICES 308, LLC | 1 | $1.2M | Oct 28, 2025 |
| EXELAN PHARMACEUTICALS INC | 1 | $899K | Feb 5, 2026 |
| SIRTEX MEDICAL INC | 1 | $241K | Apr 4, 2025 |
| PETNET SOLUTIONS, INC. | 1 | $41K | Aug 3, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- $CAH reported $254.2B revenue (fiscal year ending Jun 30, 2026). The median single-winner award in these 8 past awards, $775K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Aug 3, 2026PETNET SOLUTIONS, INC.$41K6505--F18 Posluma RadiopharmaceuticalNo listed company matched (Materiality N/A)
- May 1, 2026PANHANDLE NUCLEAR RX, LTD.$650KRadiopharmaceuticalsNo listed company matched (Materiality N/A)
- Feb 5, 2026EXELAN PHARMACEUTICALS INC$899KLenalidomide Generic MedNo listed company matched (Materiality N/A)
- Oct 28, 2025OPTUM INFUSION SERVICES 308, LLC$1.2M6505--Dallas Pharmacy Compounding Oncology NTX VA Healthcare SystemNo listed company matched (Materiality N/A)
- Apr 4, 2025SIRTEX MEDICAL INC$241KSIR-SpheresNo listed company matched (Materiality N/A)
- Feb 25, 2025PANHANDLE NUCLEAR RX, LTD.$112K6505--Radiopharmaceuticals Bridge OrderNo listed company matched (Materiality N/A)
- Jan 29, 2025CARDINAL HEALTH 414, LLC$1.9M6505--Radiopharmaceuticals (STX)Materiality: <0.01% of $CAH revenue (Low) SEC
- Nov 26, 2024SOFIE Co. Dulles VA 20166 USA$1.2M6505--PET Radiopharmaceuticals in Dallas, TX area (Base 4 OYs)No listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 7 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $45K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.